MX2014007027A - Use of leuprolide acetate as a modulator of proinflammatory and factor nk-kb cytokines. - Google Patents

Use of leuprolide acetate as a modulator of proinflammatory and factor nk-kb cytokines.

Info

Publication number
MX2014007027A
MX2014007027A MX2014007027A MX2014007027A MX2014007027A MX 2014007027 A MX2014007027 A MX 2014007027A MX 2014007027 A MX2014007027 A MX 2014007027A MX 2014007027 A MX2014007027 A MX 2014007027A MX 2014007027 A MX2014007027 A MX 2014007027A
Authority
MX
Mexico
Prior art keywords
cytokines
factor
leuprolide acetate
proinflammatory
modulator
Prior art date
Application number
MX2014007027A
Other languages
Spanish (es)
Inventor
Eva Maria Salinas Miralles
Jose Luis Quintanar Stephano
Irene Guzman Soto
Original Assignee
Univ Autonoma De Aguascalientes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Autonoma De Aguascalientes filed Critical Univ Autonoma De Aguascalientes
Priority to MX2014007027A priority Critical patent/MX2014007027A/en
Publication of MX2014007027A publication Critical patent/MX2014007027A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is related to compositions useful for treating diseases associated to an elevated response to pro-inflammatory and factor NF-kB cytokines. Said compositions comprise the leuprolide acetate and at least a pharmaceutically acceptable carrier and/or a pharmaceutically acceptable excipient thereof.
MX2014007027A 2014-06-12 2014-06-12 Use of leuprolide acetate as a modulator of proinflammatory and factor nk-kb cytokines. MX2014007027A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2014007027A MX2014007027A (en) 2014-06-12 2014-06-12 Use of leuprolide acetate as a modulator of proinflammatory and factor nk-kb cytokines.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014007027A MX2014007027A (en) 2014-06-12 2014-06-12 Use of leuprolide acetate as a modulator of proinflammatory and factor nk-kb cytokines.

Publications (1)

Publication Number Publication Date
MX2014007027A true MX2014007027A (en) 2015-12-11

Family

ID=55587459

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007027A MX2014007027A (en) 2014-06-12 2014-06-12 Use of leuprolide acetate as a modulator of proinflammatory and factor nk-kb cytokines.

Country Status (1)

Country Link
MX (1) MX2014007027A (en)

Similar Documents

Publication Publication Date Title
ZA201802657B (en) Crystal forms of beta-nicotinamide mononucleotide
DK3889145T3 (en) 8-cyano-5-piperidino-quinolines as TLR7/8 antagonists and uses thereof for the treatment of immune diseases
EA201691582A1 (en) NEW PHARMACEUTICAL PREPARATIONS
IL255509B (en) Compounds as ccr2 modulators, pharmaceutical compositions comprising same and their use for the treatment of diseases
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
IN2014CH00247A (en)
MX2017008386A (en) Site specific dosing of a btk inhibitor.
PH12017500737A1 (en) Kcnq2-5 channel activator
MX2017001352A (en) Pyrrolidinone derivatives as metap-2 inhibitors.
PH12017500181A1 (en) Article and method for maintaining menstrual fluid within the vagina
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MX2021007899A (en) Selective il-6-trans-signalling inhibitor compositions.
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
MX2017014456A (en) Therapeutic uses of l-4-chlorokynurenine.
ZA201703467B (en) Methods of treating ocular conditions
MX2020009966A (en) Dosage forms and therapeutic uses l-4-chlorokynurenine.
IN2014CH00840A (en)
MX2019001634A (en) Amide compounds, pharmaceutical compositions thereof, and methods of using the same.
CL2016002321A1 (en) Compounds derived from 2-8-5-chloropyrimidin-2-ylamino-6,7,8,9-tetrahydro-5h-pyrido3,2-bindol-5-ylacetic acid, modulators of the prostaglandin d2 receptor pharmaceutical composition and its use for the treatment of diseases allergic immune disorders.
PH12017501694A1 (en) Compositions for the treatment of fibrosis and fibrosis-related diseases
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
MX2014007027A (en) Use of leuprolide acetate as a modulator of proinflammatory and factor nk-kb cytokines.
IN2014MU00859A (en)
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.
MX2017013103A (en) Methods for the treatment of cardiovascular disorders.